Related by context. Frequent words. (Click for all words.) 82 Drug Candidate 80 Preclinical Data 80 Monoclonal Antibody 79 Small Molecule 77 Inhibits 77 Recombinant Human 77 Clinical Trial Results 76 Presents Positive 75 Initiate Phase 74 Well Tolerated 74 Completes Enrollment 74 RNAi Therapeutics 74 Phase III Clinical Trial 74 Chronic Hepatitis C 74 Induces 73 Initiates Phase 73 Inhibitor 72 Pivotal Phase III 72 Targeted Therapy 72 FDA Clears 72 Combination Therapy 72 Cancer Cells 72 Kinase 72 Phase III Trial 72 II Clinical Trial 71 Patient Enrollment 71 Metastatic Melanoma 71 Low Dose 71 Pivotal Phase 71 Aliskiren 71 FDA Accepts 71 Kinases 71 Hepatitis C Virus 71 Phosphorylation 71 Drug Resistant 71 Study Demonstrates 71 Dasatinib 71 Factor VIIa 70 Gastric Cancer 70 Autoimmune Disease 70 Patent Covering 70 HCV protease 70 Monotherapy 70 multi kinase inhibitor 70 kinase inhibitor 70 Monoclonal Antibodies 70 Insulin Resistance 70 Epithelial 70 Benign Prostatic Hyperplasia 70 Abstract Number 69 Receives FDA Clearance 69 selectively inhibits 69 Immunogenicity 69 Pulmonary Arterial Hypertension 69 Autoimmune Diseases 69 induces apoptosis 69 Antisense 69 Cancer Vaccines 69 Meta Analysis 69 Epratuzumab 69 Irinotecan 69 Small Molecules 69 liposomal formulation 69 Bavituximab 69 proteasome inhibitor 69 Intracellular 69 Newly Diagnosed 69 MEK inhibitor 68 Cancer Therapies 68 Inhibitors 68 Solid Tumors 68 Researchers Identify 68 Bortezomib 68 Patients Treated 68 Shows Promise 68 Metastatic Colorectal Cancer 68 Polymorphism 68 Antigens 68 Voreloxin 68 sphingosine 1 68 Chronic Lymphocytic Leukemia 68 orally bioavailable 68 hypoxia inducible factor 68 Carfilzomib 68 FLT3 68 Generic Version 68 Guanilib 68 Erlotinib 67 Malaria Vaccine 67 Cethromycin 67 Bevacizumab 67 novel orally administered 67 Prostate Cancer Patients 67 Oral Presentation 67 Tesetaxel 67 Pathogenesis 67 J Am Coll 67 TLR9 agonist 67 Panzem R 67 Cancer Res 67 CCX#